Aa
Aa
A
A
A
Close
Avatar universal

effect of nucs for 5-11years on intrahbvdna cccdna

http://www.professionalabstracts.com/ilc2014/planner/index.php?go=abstract&action=abstract_show&absno=2080&

THE EFFECT OF LONG-TERM NUCLEOSIDE/TIDE ANALOGUE TREATMENT ON INTRAHEPATIC HBV DNA AND COVALENTLY CLOSED CIRCULAR DNA IN CHRONIC HEPATITIS B PATIENTS Print

D.K. Wong1,2, C.-L. Lai1,2, P. Ip3, M. Kopaniszen1, W.-K. Seto1, J. Fung1,2, F.-Y. Huang1, R. Wu1, C. Cheng1, V. Ngai1, M.-F. Yuen1,2
1Medicine, 2State Key Laboratory for Liver Research, 3Pathology, University of Hong Kong, Hong Kong, Hong Kong
E-mail: ***@****

Background and aims: Nucleoside/tide analogue (NA) treatment suppresses serum HBV DNA to very low levels. However, their long-term effects on intrahepatic HBV DNA (ihHBV-DNA) and covalently closed circular DNA (cccDNA) have never been documented.
Methods: Patients on long-term continuous (5 - 11 years) NA (lamivudine/adefovir/telbivudine/entecavir/tenofovir) were recruited. All patients had 3 liver biopsies: at baseline, after 1 year of treatment and at the last follow-up. Serum HBV DNA was measured by the COBAS TaqMan HBV Test (Roche Diagnostics). ihHBV-DNA and cccDNA were assayed by real-time PCR as previously described.1
Results: To date, 10 patients had undergone liver biopsies at the last follow-up, all of whom had either 100mg lamivudine or 0.5mg entecavir at baseline and had been switched to 1.0mg entecavir during follow-up (median follow-up: 11.4 years; range 10.7 - 11.5 years). At baseline, the median serum HBV DNA, ihHBV-DNA and cccDNA levels were 6.66 logIU/mL, 273 copies/cell, and 3.2 copies/cell, respectively. At the time of the last biopsies, although all 10 patients had serum HBV DNA levels below detection limit (< 20 IU/mL; p< 0.0001 comparing to baseline), all had detectable ihHBV-DNA and cccDNA. However, the ihHBV-DNA and cccDNA levels were greatly reduced, with median values of 0.45 and 0.04 copies/cell, respectively, and median percentage reductions of 99.9% and 98.2%, respectively (both p< 0.0001; compared to baseline levels).
Conclusions: Long-term NA treatment significantly reduced ihHBV-DNA and cccDNA, though small amount of these were still present. Whether more prolonged therapy can eradicate them is still unknown.
1. Wong et al, (2013) Clin. Gastro. Hepatol. 11:1004-10


Assigned speakers:
Ching-Lung Lai , University of Hong Kong , Hong Kong , Hong Kong

Assigned in sessions:
12.04.2014, 09:00-18:00, Poster, 7C - VIRAL HEPATITIS: HEPATITIS B & D - CLINICAL (THERAPY, NEW COMPOUNDS, RESISTANCE), Poster Exhibition
4 Responses
Sort by: Helpful Oldest Newest
Avatar universal
that s just to have an idea of the immune suppression from hbsag and balance with immune response, which you can t have from cccdna level.this will tell you if peg would clear in all of them
Helpful - 0
Avatar universal
Though not a medical professional - looks very encouraging to me and a big relieve.
Helpful - 0
Avatar universal
doesn't cccdna quantity in cell gives better understanding of what is going on inside the liver rather then measuring hbsag in blood?
Helpful - 0
Avatar universal
these reports are so poor, why not report serum hbsag?

too bad lam and etv only
Helpful - 0
Have an Answer?

You are reading content posted in the Hepatitis B Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.